Aim: Periodontitis results from bacteria-induced inflammation. A key cytokine, RANKL, is produced by a number of cell types. The cellular source of RANKL critical for periodontitis has not been established.
Many of these mediators induce bone loss by induction of receptor activator of nuclear factor kappa-B ligand (RANKL). B lymphocytes and T lymphocytes are thought to be primary sources of RANKL in periodontitis (Kawai et al., 2006; Liu et al., 2003) . In contrast, osteoblast lineage cells are an important source of RANKL in conditions characterized by unloading of mechanical forces, bone loss induced by ovariectomy or arthritis, whereas the loss of RANKL in T lymphocytes does not confer such protection (Fumoto, Takeshita, Ito, & Ikeda, 2014; Nakashima et al., 2011; Xiong et al., 2011) . Moreover, we have shown that the induction of periodontal disease in mice stimulates RANKL production in bone-lining osteoblastic cells and osteocytes . However, the specific role of osteocytes in contributing to bacteria-induced periodontal bone loss has not been investigated.
To investigate the role of osteocytes in periodontitis, we examined mice with conditional deletion of floxed RANKL by Cre recombinase driven by a promoter element from the dentin matrix acidic phosphoprotein 1 (DMP1) gene. DMP1 is an extracellular matrix protein found in bone and dentin (D'Souza et al., 1997; George, Sabsay, Simonian, & Veis, 1993 ). Recent studies demonstrate that osteocytes express high levels of DMP1 in a lineage-specific manner along with odontoblasts (Fen et al., 2002; Komori, 2014) . Mice with DMP-1-driven Cre recombinase and floxed RANKL have RANKL expression that is specifically blocked in osteocytes (Xiong et al., 2011) . While this significantly reduces bone resorption associated with unloading in adult mice, during development, they have normal cancellous bone formation and normal tooth eruption indicating that osteocyte-produced RANKL is most important in processes that occur after development.
We show here that specific deletion of RANKL in osteocytes blocks bacteria-induced periodontal bone loss in both normoglycaemic conditions and when periodontal disease is enhanced by diabetes. These data show for the first time that osteocytes play an important role in periodontitis. Little Rock, AR. They were obtained by breeding DMP-1. Cre recombinase transgenic mice originally described in ref (Feng et al., 2006) with floxed RANKL transgenic mice originally described in ref (Xiong et al., 2011) . They express Cre recombinase under a control element of the Dmp1 promoter so that expression is restricted to osteocytes and odontoblasts (Lu et al., 2007 
| MATERIALS AND METHODS

| Inoculation of bacteria and tissue harvest
Mice were pre-treated with trimethoprim (1.6 mg/ml) and sulfadimethoxine (8 mg/ml) added to the drinking water which was changed every other day and given for 7 consecutive days to reduce the endogenous oral bacteria. Porphyromonas gingivalis (Pg) strain (ATCC 33277) and Fusobacterium nucleatum (Fn) strain (ATCC 25586) were inoculated in 100 μl of sterile methylcellulose so that 2 × 10 9 colony-forming units of each bacterium were applied in 200 μl of 2% methylcellulose. Oral inoculation with Porphyromonas gingivalis-Fusobacterium nucleatum bacteria (Pg-Fn) is an effective model for studying periodontitis (Polak et al., 2009 ) and a dose which we have previously published and found to be effective in mice with a C57/B6 background .
Bacterial inoculation was performed three times per week over a 2-week period. Mice were euthanized at 6 weeks after the last bacterial inoculation by decapitation under anaesthesia. Specimens were fixed in 4% paraformaldehyde at 4°C for 24 hr, transferred to PBS, taken for micro-CT analysis and subsequently decalcified in 10% EDTA (Fisher Scientific; Hampton, New Hampshire) for 4-5 weeks. The specimens were embedded in paraffin and sectioned in sagittal sections of 4-μm thickness that included the region of the molar teeth.
| Analysis of bone
Specimens were examined with a MicroCT scanner (viva CT40 SCANCO Medical, Brüttisellen, Switzerland) and analysed using
Clinical Relevance
Scientific Rationale: It is well known that periodontitis involves bone loss that is stimulated by inflammation. RANKL is critical cytokine in this process although its key cellular source in periodontitis is unknown.
Findings:
We show for the first time through lineage-specific deletion of RANKL, the surprising role of osteocytes in bacteria-induced periodontal bone loss under both normoglycaemic conditions and in diabetes-enhanced periodontitis.
Implications:
The results provide new insight into the aetiology of periodontal bone loss by describing how inflammation affects bone cells, particularly osteocytes to induce periodontal bone resorption through RANKL production.
OsiriX MD imaging software (Pixmeo; Geneva, Switzerland). The bone area between the first and second molar was measured in sagittal slices between the distobuccal root of the first molar and the mesiobuccal root of the second molar. The micro-CT slice that gave the most bone loss inter proximally was examined for bone area coronally from the cement-enamel junctions ( the second molar as we have previously described (Wu et al., 2016) .
We focused on the bone adjacent to the second molar because of the "distal drift" of teeth noted in the mouse (Gilmore & Glickman, 1959) . The number of osteoclasts and the corresponding length of bone was measured using image analysis (NIS-Elements, Nikon), and the data are presented as the number of osteoclasts per mm bone length. The per cent eroded bone surface was measured in TRAPstained sections. The same bone surface examined for osteoclasts was assessed by image analysis for the per cent of the bone length that had resorption lacunae as we have described .
| Immunofluorescence
RANKL was examined by immunofluorescence following antigen retrieval with proteinase K, blocking of non-specific sites with donkey serum in blocking buffer and incubation with primary antibody specific for RANKL (sc-7628) from Santa Cruz Biotechnology (Santa Cruz, California) at 2 μg/ml or normal goat IgG control at 2 μg/ml.
Specimens were then incubated with biotinylated secondary antibody (Jackson Immuno Research; West Grove, Pennsylvania) and avidin-biotin complex (ABC Vector Elite; Vector Labs) followed by tyramide signal amplification. Specimens were mounted in mounting media containing DAPI. Mean fluorescence intensity was measured with capture time set so that the highest group had a maximum fluorescence intensity of 3,000 to ensure that measurements were made within a linear range of detection as we have previously described (Xu et al., 2015) . Six to seven images were captured of the alveolar bone between the first and second molar, the connective tissue above the bone crest and subepithelial connective tissue.
Images were captured using a fluorescence microscope (Eclipse 90i; Nikon) and analysed with Nikon AR image analysis software (Nikon). Beta-galactosidase was assessed by immunofluorescence using the same approach except that antigen retrieval was performed by immersing slides in citric acid (pH 6.0, 10 mM) at 95°C
for 15-20 min. Primary antibody specific for beta-galactosidase was purchased from Bioss Antibodies (Woburn, Massachusetts) and compared to matched control rabbit IgG. Sections were counterstained with DAPI. 
| Statistical analysis
Statistical analyses were performed using GraphPad Prism6 Software (La Jolla, California). The Kruskal-Wallis non-parametric analysis of variance test was used to establish differences between infected and non-infected mice within each wild-type or transgenic group, and the Kolmogorov-Smirnov non-parametric t test was used to establish differences between WT and transgenic (RANKL ablated) mice for each parameter. The significance level was set at p < .05, and each group had 5-7 mice with the mouse set as the unit of measurement.
| RESULTS
| Tissue specificity of Dmp1-Cre mice
Beta-galactosidase immunofluorescence analysis of ROSA26 reporter mice (DMP1-Cre 
| Analysis of bone loss
In the normoglycaemic (NG) group, oral infection induced periodontal bone loss in the wild-type mice while little to no bone loss was detected in the experimental (DMP1−Cre Figure 2d ).
| Osteoclast numbers
Osteoclasts were counted in TRAP-stained sections (Figure 3a ). In the normoglycaemic group, oral infection stimulated a fourfold increase in osteoclasts in the WT normoglycaemic mice and a sevenfold increase 
| RANKL immunofluorescence
Induction of experimental periodontitis stimulated RANKL expression in WT mice but not experimental (DMP1−Cre 
| DISCUSSION
We found that osteocytes play a critical role in infection-induced periodontal bone loss based on findings that osteocyte-lineage deletion of RANKL blocks bacteria-induced periodontal bone loss and osteoclastogenesis. Deletion of RANKL in osteocytes had the same impact on halting periodontal bone loss in diabetic animals as it did in their normoglycaemic counterparts. Inflammatory cells mediate bacteria-induced osteoclastogenesis and bone resorption (Hajishengallis, Lamont, & Graves, 2015; Xiao, Li, Pacios, Wang, & Graves, 2016) . It has been previously reported that in animal models and human specimens, a major source of RANKL associated with periodontitis is lymphocytes (Kanzaki et al., 2016; Kawai et al., 2006; Lin, Han, Kawai, & Taubman, 2010) . To our knowledge, the expression of RANKL by osteocytes in humans has not been examined. We have previously shown that the introduction of periodontal pathogens to the oral cavity of mice induces NF-kB and RANKL expression in osteoblastic bone-lining cells and osteocytes . Although we saw statistical differences in bone resorption and osteoclast numbers and activity between WT and experimental mice, we cannot rule out the possibility that leucocyte sources of RANKL may also play a role in periodontal bone loss. It is clear though that osteocytes, which have not been previously thought of as a key producer of RANKL in periodontal bone loss, should be considered as an important source of RANKL in periodontitis as it is in other bone pathologies such as osteoporosis, rheumatoid arthritis and fatigue-induced microdamage (Kennedy et al., 2012; O'Brien, Nakashima, & Takayanagi, 2012; Xiong et al., 2011) .
Our results are also consistent with RANKL playing a prominent role in stimulating periodontal bone loss enhanced by diabetic conditions (Wu, Xiao, & Graves, 2015) . We found that the diabetic group had a consistently high level of bone loss, consistent with earlier studies in animals Pacios et al., 2012) and humans. Diabetes can enhance bone loss through the upregulation of the inflammatory response which regulates osteoclastogenesis and causes uncoupling of bone formation following resorption in part due to increased apoptosis of osteoblast lineage cells (Pacios et al., , 2013 . This agrees with findings that diabetes up-regulates and prolongs inflammation that increases RANKL expression (Naguib, Al-Mashat, Desta, & Graves, 2004; Ribeiro et al., 2011; Xiao et al., 2017) . Diabetes-enhanced inflammation also alters the microbiome to render it more pathogenic and capable of inducing higher RANKL expression (Xiao et al., 2017) . We found that RANKL produced by osteocytes was highest in the diabetic impacted group than matched normoglycaemic animals, which coincided with increased osteoclast numbers and osteoclast activity reflected by an increased eroded bone surface.
The findings of this study shed light on the cellular regulation of bone resorption and the role of osteocytes in the disease process. We demonstrate for the first time the important role of osteocytes in periodontal bone loss through the expression of RANKL. This finding may contribute to future studies that target osteocytes to provide a greater understanding how they contribute to inflammatory bone loss under both normoglycaemic and diabetic conditions.
